Chronic Plaque Psoriasis Market Analysis 2025: Comprehensive Overview & Emerging Opportunities

24 Apr, 2025

The Chronic Plaque Psoriasis Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.

What are the Historical Growth Trends in the Chronic Plaque Psoriasis Market?

The market size of chronic plaque psoriasis has seen significant growth recently. In 2024, the market was valued at $20.79 billion and it is projected to reach $22.32 billion in 2025, expanding at a compound annual growth rate (CAGR) of 7.3%.

What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Chronic Plaque Psoriasis Industry?

The Chronic Plaque Psoriasis market is projected to reach a value of $29.33 billion by 2029, growing at a CAGR of 7.1%.

Download Your Free Sample of the 2025 Chronic Plaque Psoriasis Market Report and Uncover Key Trends Now!

What are the Key Growth Drivers Fueling the Chronic Plaque Psoriasis Market?

The key drivers in the chronic plaque psoriasis market are:

•Rising prevalence of chronic plaque psoriasis globally
•Increase in autoimmune diseases
•Growth in healthcare budgets
•Increasing demand for effective treatments.

Global Market Segmentation: Identifying Major Chronic Plaque Psoriasis Industry Segments

The chronic plaque psoriasis market covered in this report is segmented –
1) By Drug Class: Biologics, Small Molecule Drugs
2) By Route Of Administration: Injectable, Oral, Topical
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy Subsegments:
1) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors (IL-12, IL-23, IL-17, IL-2), T-Cell Inhibitors, Others
2) By Small Molecule Drugs: Phosphodiesterase 4 (PDE) Inhibitors, Janus Kinase (JAK) Inhibitors, Retinoids, Others

Pre-order the 2025 Chronic Plaque Psoriasis Global Market Report for Fast Delivery & Comprehensive Insights!

What are the emerging Trends Shaping the Future of the Chronic Plaque Psoriasis Market?

The key trends in the chronic plaque psoriasis market are:

•The chronic plaque psoriasis market is seeing a significant push towards advancements in biologic treatments.
•Introduction of oral small molecule inhibitors is a developing trend.
•There is a surging trend towards the integration of digital health.
•Personalized medicine and introduction of biosimilars are significantly shaping the market trend.

Who Are the Top Competitors & Leading Players in the Chronic Plaque Psoriasis Market?

Major players in the chronic plaque psoriasis market are:

• Pfizer Inc.
• Johnson & Johnson
• Merck & Co. Inc.
• AbbVie Inc.
• Bristol-Myers Squibb Company
• Novartis AG
• Eli Lilly and Company
• Amgen Inc.
• Boehringer Ingelheim
• Biogen Inc.
• UCB S.A.
• Dr. Reddy’s Laboratories
• Innovent Biologics Inc.
• Dong-A ST Co. Ltd.
• Alumis GmbH Co KG
• Zai Lab Limited
• GC Cell Corporation
• Affibody AB
• Nimbus Therapeutics
• Bio-Thera Solutions
• Can-Fite Biopharma
• Celgene Corporation
• Kadmon Pharmaceuticals
• Aldeyra Therapeutics Inc.
• Arcutis Biotherapeutics

Regional Dominance: Which Area Leads the Global Template Market?

North America was the largest region in the chronic plaque psoriasis market in 2024